...
首页> 外文期刊>Journal of Medicinal Chemistry >Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.
【24h】

Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.

机译:α-核苷的设计,合成和抗病毒活性:呋喃呋喃糖基和(5-脱氧呋喃呋喃糖基)苯并咪唑的D-和L-异构体。

获取原文
获取原文并翻译 | 示例
           

摘要

Several 2-substituted alpha-D- and alpha-L-lyxofuranosyl and 5-deoxylyxofuranosyl derivatives of 5,6-dicholro-2-(isopropylamino)-1-(beta-L-ribofuranosyl) benzimidazole (1263W94) and 2,5,6-trichloro-1(beta-D-ribofuranosyl)benzimidazole (TCRB) were synthesized and evaluated for activity against two herpesviruses (HSV-1 and HCMV) and for their cytotoxicity against HFF and KB cells. Condensation of 1,2,3,5-tetra-O-acetyl-L-lyxofuranose (2a) with 2,5,6-trichlorobenzimidazole (1) yielded the alpha-nucleoside 3a. The 2-bromo derivative and 2-methylamino derivative were prepared by treatment of 3a with HBr followed by deprotection or from methylamine, respectively. Compound 3a was deprotected and the resultant nucleoside used to prepare the 2-cyclopropylamino and 2-isopropylamino derivatives. The 2-alkylthio nucleosides were prepared by condensing 2a with 5,6-dichlorobenzimidazole-2-thione followed by deprotection. Alkylation of this adduct gave the 2-methylthio and 2-benzylthio derivatives. Condensation of 5-deoxy-1,2,3-tri-O-acetyl-L-lyxofuranosyl, prepared from L-lyxose, with 1 or 2-bromo-5,6-dichlorobenzimidazole (15), followed by deprotection, gave the 2-chloro or 2-bromo-5'-deoxylyxo-furanosyl derivative, respectively. The cyclopropylamino derivative was prepared from the 2-chloro derivative. All D-isomers were prepared in an analogous fashion from D-lyxose. Either compounds were inactive against HSV-1 or weak activity was poorly separated from cytotoxicity. In contrast, the 2-halogen derivatives in both the alpha-lyxose and 5-deoxy-alpha-lyxose series were active against the Towne strain of HCMV. The 5-deoxy alpha-L analogues were the most active, IC50's = 0.2-0.4 microM, plaque assay; IC90's = 0.2-2 microM, yield reduction assay. All of the 2-isopropylamino or 2-cyclopropylamino derivatives were less active (IC50's = 60-100 microM, plaque assay; IC90's = 17-100 microM, yield reduction assay) and were not cytotoxic. The methylamino, thio, and methylthio derivatives were neither active nor cytotoxic. The benzylthio derivatives were weakly active, but this activity was poorly separated from cytotoxicity. The alpha-lyxose L-isomers were more active in a plaque assay against the AD169 strain of HCMV compared to the Towne strain, thereby providing additional evidence of antiviral specificity.
机译:5,6-二氯-2-(异丙氨基)-1-(β-L-呋喃呋喃糖基)苯并咪唑(1263W94)和2,5的几种2-取代的α-D-和α-L-呋喃呋喃糖基和5-脱氧呋喃呋喃糖基衍生物合成6-三氯-1(β-D-呋喃呋喃糖基)苯并咪唑(TCRB),并评估其对两种疱疹病毒(HSV-1和HCMV)的活性以及对HFF和KB细胞的细胞毒性。 1,2,3,5-四-O-乙酰基-L-呋喃呋喃糖(2a)与2,5,6-三氯苯并咪唑(1)缩合产生α-核苷3a。通过用HBr处理3a,然后脱保护或从甲胺制备2-溴衍生物和2-甲基氨基衍生物。将化合物3a去保护,并将所得核苷用于制备2-环丙基氨基和2-异丙基氨基衍生物。通过将2a与5,6-二氯苯并咪唑-2-硫酮缩合,然后脱保护来制备2-烷硫基核苷。该加合物的烷基化得到2-甲硫基和2-苄硫基衍生物。由L-糖制得的5-脱氧-1,2,3-三-O-乙酰基-L-呋喃糖基与1或2-溴-5,6-二氯苯并咪唑(15)缩合,然后脱保护,得到分别是2-氯或2-溴-5'-脱氧lyxo-呋喃糖基衍生物。由2-氯衍生物制备环丙基氨基衍生物。所有D-异构体均以类似的方式由D-lyxose制备。化合物对HSV-1无活性,或者弱活性与细胞毒性分离差。相比之下,α-lyxose和5-deoxy-α-lyxose系列中的2-卤素衍生物对HCMV的Towne菌株具有活性。 5-脱氧α-L类似物是最活跃的,IC 50 =0.2-0.4μM的噬菌斑测定。 IC90 =0.2-2μM,产率降低测定。所有的2-异丙基氨基或2-环丙基氨基衍生物均活性较低(IC50 = 60-100 microM,噬斑测定; IC90 = 17-100 microM,产率降低测定),并且无细胞毒性。甲氨基,硫代和甲硫基衍生物既无活性,也无细胞毒性。苄硫基衍生物活性较弱,但这种活性与细胞毒性很难分开。相较于Towne菌株,在针对HCMV AD169菌株的噬菌斑测定中,α-二糖L-异构体的活性更高,从而提供了抗病毒特异性的其他证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号